Unknown Manufacturer
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
与依维莫司联合，用于既往接受过酪氨酸激酶抑制剂治疗失败的晚期肾细胞癌患者。
